These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2342686)

  • 1. Doxorubicin induced hyperpigmentation.
    Kumar L; Kochupillai V
    N Z Med J; 1990 Apr; 103(887):165. PubMed ID: 2342686
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nail hyperpigmentation as a secondary effect of doxorubicin].
    Sanz Ortiz J; Méndez Batán MA; Fariñas Alvarez C; Gutiérrez del Río C
    Med Clin (Barc); 1982 Jun; 79(1):49-50. PubMed ID: 7121110
    [No Abstract]   [Full Text] [Related]  

  • 3. Doxorubicin-associated hyperpigmentation.
    Curran CF
    N Z Med J; 1990 Oct; 103(900):517. PubMed ID: 2234654
    [No Abstract]   [Full Text] [Related]  

  • 4. Pigmentation with doxorubicin therapy.
    Orr LE; McKernan JF
    Arch Dermatol; 1980 Mar; 116(3):273. PubMed ID: 6245620
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nail pigmentation during therapy with cyclophosphamide and doxorubicin].
    Manigand G; Faux N; Dumas D; Taillandier J; Fixy P; Richerd F
    Sem Hop; 1983 Jun; 59(24):1840-1. PubMed ID: 6136095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin and hyperpigmentation.
    Alagaratnam TT; Choi TK; Ong GB
    Aust N Z J Surg; 1982 Oct; 52(5):531-3. PubMed ID: 6959604
    [No Abstract]   [Full Text] [Related]  

  • 7. Melanocyte-stimulating-hormone levels in doxorubicin-induced hyperpigmentation.
    Kew MC; Mzamane D; Smith AG; Shuster S
    Lancet; 1977 Apr; 1(8015):811. PubMed ID: 66615
    [No Abstract]   [Full Text] [Related]  

  • 8. Nail hyperpigmentation secondary to therapy with doxorubicin.
    Giacobetti R; Esterly NB; Morgan ER
    Am J Dis Child; 1981 Apr; 135(4):317-8. PubMed ID: 7211789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Hyperpigmentation of nails from doxorubicin.
    Pratt CB; Shanks EC
    JAMA; 1974 Apr; 228(4):460. PubMed ID: 4406195
    [No Abstract]   [Full Text] [Related]  

  • 10. Blue-gray pigmentation in a patient receiving doxorubicin.
    Konohana A
    J Dermatol; 1992 Apr; 19(4):250-2. PubMed ID: 1318885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possibilities for the cure of acute myeloblastic leukemia with the modified VAPA regimen: preliminary results].
    Díaz Mediavilla J; del Potro Gómez E; Llorente Pérez L; Martínez Martínez R; Guerra Moyano JL; de la Vega Bueno E; Alvarez Carmona A; Krsnik Castelló I; Alarcón Zurita C; Rodríguez Vázquez M
    Med Clin (Barc); 1984 Dec; 83(19):783-6. PubMed ID: 6597329
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of treatment with 2 chemotherapeutic protocols (TAPA and VAPA) in acute myeloblastic leukemia].
    Avilés-Miranda A; Ambriz-Fernández R; García-Vela E; Monroy-Arellano L; Pizzuto J
    Gac Med Mex; 1984 Apr; 120(4):145-50. PubMed ID: 6593266
    [No Abstract]   [Full Text] [Related]  

  • 13. Daunorubicin and adriamycin in the treatment of leukemia.
    Klener P; Donner L; Kozená J
    Neoplasma; 1973; 20(1):87-96. PubMed ID: 4573873
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemochromatosis and anthracyclines: free-radical-mediated tissue injury?
    Moldow CF; Bloomfield CD
    Lancet; 1978 Jul; 2(8081):154-5. PubMed ID: 78352
    [No Abstract]   [Full Text] [Related]  

  • 15. Minocycline-induced hyperpigmentation.
    Hung PH; Caldwell JB; James WD
    J Fam Pract; 1995 Aug; 41(2):183-5. PubMed ID: 7636458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperpigmentation with daunorubicin therapy.
    Kelly TM; Fishman LM; Lessner HE
    Arch Dermatol; 1984 Feb; 120(2):262-3. PubMed ID: 6696484
    [No Abstract]   [Full Text] [Related]  

  • 17. [Phase II study of THP-adriamycin in acute leukemia].
    Tani Y; Hirayama F; Ogawa K; Mashimoto K; Kubota R; Kanekura J; Oguma S; Veta T; Nakamura H; Shibata M
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2573-4. PubMed ID: 6580842
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Adriamycin and longitudinal pigmented banding of fingernails.
    Priestman TJ; James KW
    Lancet; 1975 Jun; 1(7920):1337-8. PubMed ID: 49535
    [No Abstract]   [Full Text] [Related]  

  • 19. Serpentine supravenous 5-fluorouracil (NSC-19893) hyperpigmentation.
    Hrushesky WJ
    Cancer Treat Rep; 1976 May; 60(5):639. PubMed ID: 991154
    [No Abstract]   [Full Text] [Related]  

  • 20. [Amiodarone-induced hyperpigmentation].
    Török L; Szekeres L; Lakatos A; Szücs M
    Hautarzt; 1986 Sep; 37(9):507-10. PubMed ID: 3771217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.